Name | (3S,8R,9S,10R,13S,14S)-3-[2-(diethylamino)ethoxy]-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one,hydrochloride |
---|---|
Synonyms |
Androst-5-en-17-one, 3-[2- (diethylamino)ethoxy]-, hydrochloride, (3β)-
(3β)-3-[2-(Diethylamino)ethoxy]androst-5-en-17-one hydrochloride (1:1) Androst-5-en-17-one, 3β-(2-(diethylamino)ethoxy)-, hydrochloride (8CI) Androst-5-en-17-one, 3β-[2- (diethylamino)ethoxy]-, hydrochloride Androst-5-en-17-one, 3-(2-(diethylamino)ethoxy)-, hydrochloride, (3β)- Androst-5-en-17-one, 3-[2-(diethylamino)ethoxy]-, (3β)-, hydrochloride (1:1) |
Description | U18666A, a cell permeable drug, is a cholesterol synthesis and transport inhibitor. |
---|---|
Related Catalog | |
Target |
Cholesterol[1][2]. |
In Vitro | U18666A, the antiviral effect is found to result from two events: retarded viral trafficking in the cholesterol-loaded late endosomes/lysosomes and suppresse de novo sterol biosynthesis in treated infected cells. It is also observed an additive antiviral effect of U18666A with C75, a fatty acid synthase inhibitor, suggesting dengue virus relies on both the host cholesterol and fatty acid biosynthesis for successful replication[1][2]. |
References |
Molecular Formula | C25H42ClNO2 |
---|---|
Molecular Weight | 424.060 |
Exact Mass | 423.290405 |
PSA | 29.54000 |
LogP | 6.04730 |
Storage condition | 2-8℃ |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
RIDADR | NONH for all modes of transport |